Trial Management STREAM

  1. Driving Simulation Studies At Altasciences 1/30/2023

    At Altasciences, we design driving studies to achieve your objectives, leveraging extensive experience across clinical testing of cognitive effects.

  2. What Is The Secret To Ongoing TMF Health? 8/22/2023

    Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.

  3. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

  4. The Difference Between Clinical Trial Auditing And Monitoring 4/28/2025

    While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.

  5. Patient Liaison Support In Rare Disease Trials 2/11/2026

    Real stories from rare disease trials show how attentive communication, logistical coordination, and timely reimbursement reduce stress for participants while keeping long-term engagement.

  6. Say It With Technology: How Alnylam Fosters A Connected Relationship With Sites 3/12/2021

    Alnylam Pharmaceuticals is developing an entirely new class of medicines and delivered the world’s first and only approved RNAi therapeutics in 2018 and 2019. Learn how Alnylam earned its reputation among investigators as a sponsor of choice by standardizing studies on a collaborative portal more than 6 years ago and leveraging technology to deliver results.

  7. The Golden Era Of GLP-1 Drugs 10/8/2024

    As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

  8. Navigating Early Phase CNS-Active Drug Development 2/14/2023

    Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating the risk/benefit profile.

  9. Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views 9/23/2025

    Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.

  10. Disclosure As A Service ROI 6/3/2020

    How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.